With COVID-19 vaccination taking place on a full-fledged scale across the country, the Joe Biden administration had last month announced its commitment
Trxade Group Inc.
-(MEDS)
Get the latest Trxade Group Inc. (MEDS) stock news, earnings analysis, earnings conference calls, earnings transcripts from AlphaStreet.
Trxade Group, Inc. (MEDS) Q4 2020 Earnings Call Transcript
Trxade Group, Inc. (NASDAQ: MEDS) Q4 2020 earnings call dated Mar. 29, 2021 Corporate Participants: Howard Doss -- Chief Financial Officer Suren Ajjarapu -- Chief Executive
Trxade Group (MEDS) delivers annual revenue growth of 130%
Trxade (NASDAQ: MEDS) on Monday posted a 17% increase in fourth-quarter revenues to $2 million, riding on the strength of the Trxade
CEO TALKS: The story of Trxade Group (MEDS)
Probably the biggest highlight of Trxade Group Inc (NASDAQ: MEDS) is that it was set up to solve the problems faced by
Trxade Group Inc. (NASDAQ: MEDS) Q4 2020 Research Summary
Ticker MEDSExchange NASDAQFounded 2013Headquarters FloridaIndustry TechnologyMarket Cap $45 million Trxade Group Inc (NASDAQ: MEDS) has been serving pharmacies and drug manufacturers for
SingleCare deal aimed at growing subscribers: Trxade CEO Suren Ajjarapu
Trxade (NASDAQ: MEDS) may have been on a dream run of late due to the strong demand for PPE, but the drug
Trxade Group Inc. (MEDS) Q3 2020 Earnings Call Transcript
Trxade Group Inc. (NASDAQ: MEDS) Q3 2020 earnings call dated Oct. 26, 2020 Corporate Participants: Howard Doss -- Chief Financial Officer Suren Ajjarapu -- Chief Executive
Trxade (MEDS) delivers another quarter of strong revenue growth
Trxade (NASDAQ: MEDS) on Monday posted a 174% increase in third-quarter revenues to $6.3 million, riding on continued strength in PPE sales.
Trxade Group Inc. (NASDAQ: MEDS) Q3 2020 Research Summary
Ticker MEDSExchange NASDAQFounded 2013Headquarters FloridaIndustry TechnologyMarket Cap $49 million Trxade Group (NASDAQ: MEDS) operates a web-based purchasing platform that brings together independent
6 promising small-cap stocks that are relatively under the radar
When Amazon (NASDAQ: AMZN) went public in 1997, it had a market of just over $400 million, thereby falling into the small-cap
Trxade launches integrated COVID-19 risk assessment tool for corporate clients
Integrated drug procurement firm Trxade Group (NASDAQ: MEDS) on Tuesday launched a one-of-its-kind platform that brings together various services such as COVID-19
No concerns on margin side: Trxade (MEDS) CEO Suren Ajjarapu
A lot is being spoken and written about Amazon (NASDAQ: AMZN), Shopify (NYSE: SHOP) and JD.com (NASDAQ: JD) and their prospects in
Trxade Group Inc. (MEDS) Q2 2020 Earnings Call Transcript
Trxade Group Inc. (NASDAQ: MEDS) Q2 2020 earnings call dated July 27, 2020 Corporate Participants: Suren Ajjarapu -- Founder, Chairman and Chief Executive Officer
Trxade (MEDS) stock soars after a big top-line beat
Trxade (NASDAQ: MEDS) on Monday posted second-quarter revenues that more-than-tripled to $6.6 million, primarily driven by higher sales of personal protective equipment
Trxade (MEDS) aims to take on pharmacy chains with an alternate online network
Online pharmaceutical purchases have seen a steady increase in the US over the past decade and the pandemic is now expected to
A visual representation of Trxade Group (MEDS) Q1 2020 earnings
Trxade Group Inc. (NASDAQ: MEDS) reported its financial results for the quarter ended March 31, 2020, on Monday, May 4, before the